Viewing Study NCT01602003


Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2025-12-29 @ 10:33 PM
Study NCT ID: NCT01602003
Status: COMPLETED
Last Update Posted: 2012-05-18
First Post: 2012-05-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes
Sponsor: LG Life Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module